RANIVIZ Trademark

Trademark Overview

On Thursday, November 1, 2018, a trademark application was filed for RANIVIZ with the United States Patent and Trademark Office. The USPTO has given the RANIVIZ trademark a serial number of 79247097. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Monday, March 23, 2020. This trademark is owned by Bioeq AG. The RANIVIZ trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of age-related macular degeneration
raniviz

General Information

Serial Number79247097
Word MarkRANIVIZ
Filing DateThursday, November 1, 2018
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateMonday, March 23, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicines for the treatment of age-related macular degeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, March 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioeq AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Friday, April 10, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, April 9, 2020DEATH OF INTERNATIONAL REGISTRATION
Wednesday, April 8, 2020LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, April 7, 2020ASSIGNED TO LIE
Thursday, February 20, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, September 11, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, March 23, 2019REFUSAL PROCESSED BY IB
Thursday, March 7, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 7, 2019REFUSAL PROCESSED BY MPU
Thursday, February 28, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 27, 2019SUSPENSION LETTER WRITTEN
Friday, February 22, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, February 14, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 13, 2019SUSPENSION LETTER WRITTEN
Thursday, February 7, 2019ASSIGNED TO EXAMINER
Tuesday, December 18, 2018APPLICATION FILING RECEIPT MAILED
Thursday, December 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 6, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

raniviz degeneration macular related treatment medicines